| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.00086 | 1 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.00056 | 1 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.00046 | 1 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.0004 | 1 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.00046 | 1 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00021 | 1 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.00023 | 1 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | -0.00028 | 1 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.00019 | 1 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -6.4e-05 | 1 |